This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.
Device | LIAISON® XL MUREX HBsAg Qual assay and Control |
Generic Name | Test, Hepatitis B (b Core, Be Antigen, Be Antibody, B Core Igm) |
Applicant | DiaSorin Inc1951 Northwestern Avenuestillwater, MN 55082 PMA NumberP190017 Supplement NumberS004 Date Received02/04/2022 Decision Date05/05/2022 Product Code LOM Advisory Committee Microbiology Supplement Typereal-time Process Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No |
Date Received | 2022-02-04 |
Decision Date | 2022-05-05 |
PMA | P190017 |
Supplement | S004 |
Product Code | LOM |
Advisory Committee | Microbiology |
Supplement Type | Real-time Process |
Supplement Reason | Change Design/components/specifications/material |
Expedited Review | No |
Combination Product | No |
Applicant Address | DiaSorin Inc 1951 Northwestern Avenue stillwater, MN 55082 PMA NumberP190017 Supplement NumberS004 Date Received02/04/2022 Decision Date05/05/2022 Product Code LOM Advisory Committee Microbiology Supplement Typereal-time Process Supplement Reason Change Design/components/specifications/material Expedited Review Granted? No Combination ProductNo Approval Order Statement To Allow The LIAISON XL Analyzer To Be Connected To The Beckman DxA 5000, An FDA-cleared Third Party Laboratory Automation System (LAS). |
Supplement Number | Date | Supplement Type |
---|---|---|
P190017 | Original Filing | |
S010 | 2022-11-10 | 30-day Notice |
S009 | ||
S008 | 2022-09-21 | Real-time Process |
S007 | ||
S006 | 2022-04-05 | Real-time Process |
S005 | 2022-04-05 | 30-day Notice |
S004 | 2022-02-04 | Real-time Process |
S003 | 2021-11-19 | Real-time Process |
S002 | 2021-05-27 | Real-time Process |
S001 |